229 Suppression of TGF-beta2 in pancreatic cancer by the antisense oligonucleotide ap 12009: preclinical efficacy data as basis for clinical studies
G. Stauder, P. Jachimczak, R. Schlingensiepen, M. Goldbrunner, K. Graf, M. Kielmanowicz, M. Hafner, M. Szyrach, A. BischofVolume:
1
Year:
2003
Language:
english
DOI:
10.1016/s1359-6349(03)90262-x
File:
PDF, 164 KB
english, 2003